DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Decadron (Dexamethasone) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (44)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Decadron (Dexamethasone) death. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 44   Next >>

Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in

Reported by a physician from United States on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Indication: Acute Lymphocytic Leukaemia

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: unk
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia

Decadron
    Dosage: 10 mg/m2, cyclic
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Oncaspar
    Dosage: unk, cyclic
    Indication: Acute Lymphocytic Leukaemia



Possible Decadron side effects in

Reported by a physician from Korea, Republic of on 2012-08-15

Patient:

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Decadron
    Dosage: 40 mg, cyclic
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: 9 mg/m2, cyclic
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-07-31

Patient: female, weighing 34.5 kg (75.9 pounds)

Reactions: White Blood Cell Count Decreased, Urinary Tract Infection, Febrile Neutropenia, Multiple Myeloma, Neutrophil Count Decreased, Hypertension

Adverse event resulted in: death, disablity

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-22

Decadron
    Dosage: 6.6mg x 2
    Start date: 2010-10-30
    End date: 2010-11-02

Decadron
    Dosage: 1.65g x 1
    Start date: 2010-10-30
    End date: 2010-11-02

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2010-11-27
    End date: 2010-12-02

Decadron
    Dosage: 6.6mg x 5
    Start date: 2010-10-10
    End date: 2010-10-13

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-10-30
    End date: 2010-11-19

Decadron
    Dosage: 6.6mg x 5
    Indication: Multiple Myeloma
    Start date: 2010-10-02
    End date: 2010-10-05

Other drugs received by patient: Omeprazole; Lasix; Fentanyl-100; Lasix; Orgaran; Loxonin; Neophyllin



Possible Decadron side effects in 65 year old

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: 65 year old

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, Hypotension, International Normalised Ratio Increased, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Alkeran
    Indication: Product Used FOR Unknown Indication

Decadron
    Indication: Product Used FOR Unknown Indication



Possible Decadron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-10

Patient:

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Acidosis, Prothrombin Time Prolonged, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, White Blood Cell Count Decreased, Blood Alkaline Phosphatase Increased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 mg, qw
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-07-31
    End date: 2010-08-28

Decadron
    Dosage: 12 mg, qd
    Administration route: Oral
    Start date: 2010-11-12
    End date: 2010-11-15

Revlimid
    Dosage: 25 mg, qd
    Indication: Multiple Myeloma
    Start date: 2010-08-15

Other drugs received by patient: Alkeran



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02

Patient: female, weighing 95.2 kg (209.4 pounds)

Reactions: Confusional State, Hypoglycaemia, Blood Albumin Decreased, Prothrombin Time Prolonged, Acidosis, Blood Fibrinogen Decreased, Oedema Peripheral, Blood Creatinine Increased, Renal Failure Acute, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, International Normalised Ratio Increased, Hypotension, Haemoglobin Decreased, Sepsis, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-07-31
    End date: 2010-08-28

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-08-15
    End date: 2010-08-30

Decadron
    Dosage: 12 milligram
    Administration route: Oral
    Start date: 2010-11-12
    End date: 2010-11-15

Alkeran
    Dosage: 14 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-11-12
    End date: 2010-11-15



Possible Decadron side effects in 76 year old male

Reported by a physician from Japan on 2012-06-19

Patient: 76 year old male, weighing 51.0 kg (112.2 pounds)

Reactions: Pulmonary Tuberculosis, Hepatic Neoplasm Malignant, Palmar-Plantar Erythrodysaesthesia Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Nexavar
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2009-10-21
    End date: 2009-11-01

Decadron
    Dosage: daily dose 2 mg
    Administration route: Oral
    Indication: Neoplasm Malignant
    Start date: 2011-06-20
    End date: 2011-08-08

Nexavar
    Dosage: 400 mg (daily dose), , oral
    Administration route: Oral
    Start date: 2009-11-09
    End date: 2011-08-08

Other drugs received by patient: Mucosolvan; Naproxen; Aspirin; Lansoprazole; Lasix; Levofloxacin; Urso 250; Ticlopidine HCL



Possible Decadron side effects in 77 year old male

Reported by a physician from United States on 2012-06-19

Patient: 77 year old male

Reactions: Weight Decreased, White Blood Cell Count Decreased, Pyrexia, Fall, Delirium, Aspergillosis, Platelet Count Decreased, non-Hodgkin's Lymphoma, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Proscar; Folic Acid; Potassium Chloride; Ferrous Sulfate; Prochlorperazine Maleate; Prochlorperazine Maleate



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13

Patient: female

Reactions: Hypoxic-Ischaemic Encephalopathy, Cardio-Respiratory Arrest, Aspiration, Pneumothorax

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 20 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-06-21

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-06-22

Other drugs received by patient: Omeprazole; Procrit; Aspirin; Digoxin; Senna-Mint WAF; Aldactone; Coumadin; Blood Transfusion; Citalopram; Metronidazole



Possible Decadron side effects in 77 year old male

Reported by a physician from United States on 2012-06-08

Patient: 77 year old male

Reactions: Weight Decreased, White Blood Cell Count Decreased, Pyrexia, Fall, Delirium, Aspergillosis, Platelet Count Decreased, non-Hodgkin's Lymphoma, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Potassium Chloride; Ferrous Sulfate; Proscar; Folic Acid; Prochlorperazine Maleate; Prochlorperazine Maleate



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: female, weighing 60.0 kg (132.0 pounds)

Reactions: Back Pain, Death, Arthralgia, Pain in Extremity, Hypotension, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-11-08
    End date: 2010-11-09

Velcade
    Dosage: 2 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2010-11-08
    End date: 2010-11-08



Possible Decadron side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-18

Patient: 45 year old female

Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Breast Cancer Metastatic, Joint Swelling, Rash Maculo-Papular, Metastases To Central Nervous System, Purulent Discharge, Skin Toxicity, Scab, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, DRY Skin, Diarrhoea, Gait Disturbance

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Lapatinib
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Capecitabine
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Acyclovir

Other drugs received by patient: Herceptin; Zoledronate Disodium



Possible Decadron side effects in female

Reported by a physician from Japan on 2012-05-18

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Anal Fistula, Oesophageal Candidiasis, Subcutaneous Abscess, Rectal Perforation, Gastric Ulcer, Disease Progression

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Start date: 2011-08-11
    End date: 2011-09-22

Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Start date: 2011-05-19
    End date: 2011-01-01

Lobu
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2010-11-18
    End date: 2011-11-01

Decadron
    Dosage: dosage is uncertain.
    Indication: Product Used FOR Unknown Indication

Avastin
    Start date: 2010-08-05
    End date: 2011-01-06

Avastin
    Start date: 2011-03-17
    End date: 2011-04-28

TS-1
    Dosage: it is two administering weekly holiday medicine for two weeks.
    Administration route: Oral
    Indication: Rectal Cancer Metastatic
    Start date: 2011-08-11
    End date: 2011-09-21

Irinotecan Hydrochloride
    Dosage: dosage is uncertain.
    Indication: Rectal Cancer Metastatic
    Start date: 2011-04-28
    End date: 2011-04-28

Avastin
    Start date: 2011-08-11
    End date: 2011-09-22

Avastin
    Indication: Rectal Cancer Metastatic
    Start date: 2009-11-04
    End date: 2010-04-21

Other drugs received by patient: Fluorouracil; Levoleucovorin Calcium; Levoleucovorin Calcium; Vectibix; Fluorouracil; Fluorouracil; Fluorouracil



Possible Decadron side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-14

Patient: 43 year old female, weighing 79.0 kg (173.8 pounds)

Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Treatment Noncompliance, Nail Infection, Fatigue, Urinary Tract Disorder, Balance Disorder, Dyspepsia, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral

Decadron
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-12

Decadron
    Administration route: Oral

Etoposide
    Indication: Brain Cancer Metastatic
    Start date: 2011-10-24

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Decadron
    Administration route: Oral

Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2011-10-24

Decadron Phosphate

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-02-23

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Start date: 2011-03-14

Other drugs received by patient: Lapatinib



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-08

Patient: female

Reactions: Skin Chapped, Abdominal Pain, Muscle Atrophy, Headache, Erythema, Malaise, Bronchitis Viral, Ingrowing Nail, Localised Infection, Cushingoid, Pain in Extremity, Bursitis, LIP Ulceration, Myopathy, Joint Swelling, Metastases To Central Nervous System, Rash Maculo-Papular, Purulent Discharge, Scab, Skin Toxicity, Death, Fatigue, Skin Ulcer, Chest Pain, Dizziness, Abdominal Distension, Oedema, Coordination Abnormal, Gastrooesophageal Reflux Disease, Rash Pustular, Vomiting, Gastrointestinal Toxicity, Muscular Weakness, Palmar-Plantar Erythrodysaesthesia Syndrome, DRY Skin, Rash, Diarrhoea, Gait Disturbance

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Capecitabine
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Acyclovir

Lapatinib
    Indication: Breast Cancer Metastatic
    Start date: 2011-03-04

Other drugs received by patient: Herceptin; Zoledronate Disodium



Possible Decadron side effects in female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-03

Patient: female

Reactions: Confusional State, Drug Ineffective, Mouth Ulceration, Headache, Nail Infection, Treatment Noncompliance, Fatigue, Urinary Tract Disorder, Dyspepsia, Balance Disorder, Ingrowing Nail, Oedema, Food Craving, Pyuria, Drooling, Vomiting, Nausea, Hypoaesthesia, Neutrophilia, Aggression, Dysarthria, Breast Cancer Metastatic, Diarrhoea, Pollakiuria, Tooth Disorder

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral

Carboplatin
    Indication: Breast Cancer Metastatic
    Start date: 2011-10-24

Lapatinib
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-09-21

Decadron Phosphate

Etoposide
    Indication: Brain Cancer Metastatic
    Start date: 2011-10-24

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System

Decadron
    Administration route: Oral

Decadron
    Administration route: Oral

Decadron
    Administration route: Oral
    Start date: 2011-10-03
    End date: 2011-10-12

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Indication: Breast Cancer Metastatic
    Start date: 2011-02-22
    End date: 2011-02-23

Capecitabine
    Dosage: 2 weeks out of every 3
    Administration route: Oral
    Start date: 2011-03-14



Possible Decadron side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-06

Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Zygomycosis, Pneumonia, Diabetes Mellitus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Insulin; Habekacin; Idamycin; Targocid; Ambisome; Vesanoid; Ciprofloxacin; Diflucan; Zosyn; Doripenem Monohydrate



Possible Decadron side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-13

Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Idamycin; Insulin; Zosyn; Ambisome; Vesanoid; Targocid; Ciprofloxacin; Armodafinil; Habekacin; Doripenem Monohydrate



Possible Decadron side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-03-07

Patient: 72 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron

Other drugs received by patient: Zosyn; Vesanoid; Targocid; Insulin; Idamycin; Ciprofloxacin; Armodafinil; Ambisome; Habekacin; Doripenem Monohydrate



Possible Decadron side effects in 76 year old male

Reported by a physician from Japan on 2012-03-06

Patient: 76 year old male, weighing 51.0 kg (112.2 pounds)

Reactions: Pulmonary Tuberculosis, Palmar-Plantar Erythrodysaesthesia Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Nexavar
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2009-10-21
    End date: 2009-11-01

Decadron
    Dosage: daily dose 2 mg
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-06-20
    End date: 2011-08-08

Nexavar
    Dosage: 400 mg (daily dose), , oral
    Administration route: Oral
    Start date: 2009-11-10
    End date: 2011-08-08

Other drugs received by patient: Naproxen; Aspirin; Urso 250; Levofloxacin; Mucosolvan; Ticlopidine HCL; Lansoprazole; Lasix



Possible Decadron side effects in 45 year old female

Reported by a physician from United States on 2012-03-01

Patient: 45 year old female

Reactions: Encephalitis Herpes

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron



Possible Decadron side effects in 55 year old male

Reported by a physician from United States on 2012-03-01

Patient: 55 year old male

Reactions: Encephalitis Herpes

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Decadron
    Administration route: Oral
    Indication: Malignant Melanoma

Decadron
    Administration route: Oral
    Indication: Metastases To Central Nervous System



Possible Decadron side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-28

Patient: 72 year old male, weighing 89.0 kg (195.8 pounds)

Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus

Adverse event resulted in: death

Drug(s) suspected as cause:
Tretinoin
    Dosage: 45mg/m2
    Administration route: Oral
    Indication: Acute Promyelocytic Leukaemia

Idarubicin Hydrochloride
    Indication: Acute Promyelocytic Leukaemia

Decadron
    Administration route: Oral
    Indication: Retinoic Acid Syndrome

Other drugs received by patient: Insulin



Possible Decadron side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-22

Patient: 72 year old male, weighing 89.0 kg (195.8 pounds)

Reactions: Pneumonia, Zygomycosis, Diabetes Mellitus

Adverse event resulted in: death

Drug(s) suspected as cause:
Tretinoin
    Dosage: 45mg/m2
    Administration route: Oral
    Indication: Acute Promyelocytic Leukaemia

Decadron
    Administration route: Oral
    Indication: Retinoic Acid Syndrome

Idarubicin Hydrochloride
    Indication: Acute Promyelocytic Leukaemia

Other drugs received by patient: Insulin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017